Magrolimab
Drug timelines are a Plus or Pro feature.
22 regulatory and trial events tracked for Magrolimab, covering 2021-03-01 to 2026-06-30. Get the full timeline:
Most recent: Clinical Trial Results: Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma [Phase 2]